CVRx, Inc. CVRX US — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CVRx, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: CVRx, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about CVRx, Inc.'s us — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CVRx, Inc.'s US — revenue?
- CVRx, Inc. (CVRX) reported US — revenue of $13.65M in Q1 2026.
- How has CVRx, Inc.'s US — revenue changed year-over-year?
- CVRx, Inc.'s US — revenue increased by 21.9% year-over-year, from $11.2M to $13.65M.
- What is the long-term trend for CVRx, Inc.'s US — revenue?
- Over 4 years (2021 to 2025), CVRx, Inc.'s US — revenue has grown at a 54.3% compound annual growth rate (CAGR), from $9.15M to $51.88M.
- What does US — revenue mean?
- This metric represents the total net sales generated from the sale of medical devices and related services within the United States market, excluding any collected sales taxes. It serves as a primary indicator of the company's commercial adoption, market penetration, and the effectiveness of its sales strategy for its neuromodulation technology in the domestic region. Growth in this figure reflects the successful expansion of the installed base and recurring utilization of the company's proprietary therapeutic platform.